MEOH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Methanex Corp (MEOH) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000. While the stock has shown recent price momentum and bullish technical indicators, the company's financial performance is weak, with significant declines in net income, EPS, and gross margin. Additionally, there are no strong proprietary trading signals or significant positive catalysts to justify immediate entry.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 62.895, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot point of 53.59, with resistance levels at 57.477 and 59.878. However, candlestick analysis suggests a 90% chance of a price decline in the short term (-3.61% next day, -5.99% next week, -4.33% next month).
Analysts have recently raised price targets, with a consensus view of higher methanol prices and tight supply supporting the stock in the near term. The geopolitical environment and supply constraints in the Middle East and other regions are expected to sustain higher methanol prices temporarily.
OCI Chemicals B.V.'s recent sale of 3.33 million shares, representing a significant portion of its holdings, could indicate a lack of confidence in the stock's near-term performance. Additionally, the company's weak financial performance, including a significant drop in net income (-296.91% YoY) and gross margin (-43.58% YoY), raises concerns about its operational efficiency and profitability.
In Q4 2025, Methanex reported a 2.09% YoY increase in revenue to $968.81 million. However, net income dropped significantly to -$88.76 million (-296.91% YoY), and EPS fell to -1.15 (-249.35% YoY). Gross margin also declined sharply to 7.38 (-43.58% YoY), reflecting operational challenges.
Analyst sentiment is mixed but leans positive. Recent upgrades include price targets raised to $70 (BMO Capital), $60 (Jefferies, UBS), and $59 (CIBC). However, CIBC downgraded the stock to Neutral in February, citing concerns about valuation and near-term earnings upside. The consensus view is that methanol prices will remain elevated in the short term but normalize over the next year.
